688358，拟每10股派3元

Core Viewpoint - Xiangsheng Medical (688358) announced a profit distribution plan for the first three quarters, proposing a cash dividend of 3 yuan per 10 shares to all shareholders, which reflects the company's commitment to returning value to its investors [2]. Financial Performance - As of September 30, 2025, the total share capital of the company is 112,124,537 shares, with a base for dividend calculation of 111,874,753 shares after deducting 249,784 shares in the repurchase account. The total proposed cash dividend amounts to 33.5624 million yuan (including tax), representing 35.73% of the net profit attributable to shareholders for the third quarter [5]. - For the first three quarters of the year, the company reported operating revenue of 343.166 million yuan, a decrease of 5.27% year-on-year. The net profit attributable to shareholders was 93.9205 million yuan, down 4.56% year-on-year [5][7]. - The total profit for the reporting period was 25.751 million yuan, showing a significant increase of 63.21% compared to the same period last year. However, the net profit attributable to shareholders decreased by 4.56% year-on-year [7]. Business Overview - Xiangsheng Medical specializes in the research, development, manufacturing, and sales of ultrasound medical imaging equipment. The company has developed a comprehensive set of core technologies in ultrasound imaging, including 2D, 3D, and 4D ultrasound, as well as AI cloud platform solutions [5].